Economic Atlas
Companies/Natera, Inc.
Company profile

Natera, Inc.

NASDAQ: NTRA · Healthcare · Medical - Diagnostics & Research
PublicHQ Austin, CACIK 0001604821Reports USD
#106 of 1,422 Healthcare companies by revenue73rd-percentile growth
EA Score
75B+
Revenue TTM
$2.5B
Rev growth YoY (TTM)
+36.6%
Net income (FY)
-$208.2M
Employees
6,140
as of 2026-08-04
Market cap
$38.7B
as of 2026-08-04

Financials — latest annual

SEC EDGAR · USD-normalized
ConceptUSDNativeFY
Revenue$2.3B$2.3B2025
Net income-$208.2M-$208.2M2025
Operating income-$309.9M-$309.9M2025
Total assets$2.4B$2.4B2025
Liabilities$685.9M$685.9M2025
Equity$1.7B$1.7B2025

Revenue trend

FY2019 – FY2025 · USD
FY19
FY19
FY20
FY21
FY22
FY23
FY24
FY25

Revenue by segment

Filed disclosures · FY2025
By product
Product100%
Licensing and other0%
By geography
United States98%
Europe, Middle East, India, and Africa1%
Americas, excluding U.S.0%
Asia Pacific and Other0%
The read

What is Natera, Inc.’s revenue?

Natera, Inc. booked $2.3B in FY2025 revenue, growing 36% year over year — faster than most Healthcare companies we track, at a -9.0% net margin.

Peers · Healthcare
Royalty Pharma plc72BHims & Hers Health, Inc.68BExelixis, Inc.89AEnovis Corporation66BICU Medical, Inc.78B+Concentra Group Holdings Parent, Inc.68B
Key facts
CEOSteven Leonard Chapman
SectorHealthcare
IndustryMedical - Diagnostics & Research
HeadquartersAustin, CA
ExchangeNASDAQ: NTRA
Employees6,140
IPO date2015-07-01
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.